期刊文献+

临床药代动力学中蓄积指数的计算方法及其评价 被引量:1

Evaluation and calculation of the accumulation index in clinical pharmacokinetics
下载PDF
导出
摘要 目的:多次给药的蓄积一般由药动学的蓄积指数(Rac)来表达,但计算Rac有多种方法,本文对此进行分析和评价,以确定合理的方法。方法:计算机模拟蒿乙醚真实实验的单、多次给药的血药浓度经时变化,分别采用AUC法、Cmax法、Ctrough法和模型法计算Rac,采用Bootstrap抽样法评价各法的优缺点及适用条件。结果:AUC法和Cmax法较Ctrough法和模型法更为稳定,模型法计算值偏高。药效或毒性呈浓度依赖性者,宜用Cmax法,而药效或毒性时间依赖性和体内药量依赖性时,宜用AUC法。结论:药物蓄积与有效性和安全性均相关,Rac计算方法需根据药物特性进行合理选择。 AIM: To analyze and evaluate the accumulation index (Rac) in clinical pharmacokinetics of multiple dosing administrations in order to obtain one reasonable method. METHODSThe plasma concentration-time data of arteether was simulated for 1000 subjects in multiple doses administration. The 20-40 subjects were sampled for 1000 time by the Boostrap method and values of Rac were calculated by the AUC, C Ctro.gh and model. The values of Rac were evaluated by their distributions. RESULTS:The AUC and Cmax method were more stable than the Ctrough and model method. If the efficacy or toxicity was related with the concentration, it was appropriate to use the Cmax method, and if the efficacy or toxicity was related with the time, it was appropriate to use the AUC method. CONCLUSION. The drug accumulation is related with effectiveness and safety, and the reasonable choice of Rac calculation method should be based on drug and data characteristics.
出处 《中国临床药理学与治疗学》 CAS CSCD 2013年第1期34-38,共5页 Chinese Journal of Clinical Pharmacology and Therapeutics
基金 国家科技支撑计划(2008BAI51B03) 重大新药创制新药临床评价研究技术平台(2012ZX09303-003) 上海市教委项目(E03008 J50303)
关键词 蓄积指数 药代动力学 多次给药 毒性 药效 Accumulation index Pharmacokinetics~ Multiple doses administration Toxicity Pharmacodynamics effect
  • 相关文献

参考文献10

  • 1Meineke I, Gleiter CH. Assessment of drug accu- mulation in the evaluation of pharmacokinetic data [J]. Clin Pharmacol, 1998,38(8) :680--684.
  • 2Rossum JMV. Pharmacokinetics of accumulation[J].Pharmaceutical Sciences, 1968,57 (12) : 2162 --2165.
  • 3Sunil S, Jambhekar PJB. Basic pharmacokinetics[M]. Pharmaceutical Press, 2009: 233--235.
  • 4Augsberger A. [Quantitative data on therapy with cardiac glycosides. II. The cumulation and damping of the effect] [J]. Klin Wochenschr, 1954,32 (39/ 40):945--951.
  • 5Brocks DR, Mehvar R. Rate and extent of drug ac- cumulation after multiple dosing revisited[J]. Clin Pharmacokinet, 2010,49(7): 421--438.
  • 6Colburn WA. Estimating the accumulation of drugs [J]. J PharmSei, 1983,72(7) :833--834.
  • 7叶祖光.青蒿素衍生物蒿乙醚研究简介[J].国外医学:中医中药分册,1995,17(6):6-8.
  • 8Kager PA, Schultz MJ, Zijlstra EE, et al. Ar teether administration in humans: preliminary stud ies of pharmacokineties, safety and tolerance[J]. Trans R Soc Trop Med Hyg, 1994,88 (Suppl 1) S53-- 54.
  • 9Bonate P, Howard D. Pharmacokinetics in drug de- velopment: Clinical study design and analysis [M]. AAPS Press, 2004,259--263.
  • 10Pagkalis S, Mantadakis E, Mavros MN, et al. Pharmacological considerations for the proper clini cal use of aminoglycosides [J]. Drugs, 2011,71 (17) : 2277--2294.

共引文献1

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部